Mood disorders are a category of mental health illnesses that affect a person's emotional state and overall functioning. This type of disorder is characterised by a low or depressed mood that remains persistent and can even be disabling. Other symptoms that may accompany a low mood can include feelings of emptiness, fatigue, loss of interest or pleasure in activities that were once enjoyed, difficulty concentrating or making decisions, changes in sleep and eating patterns, and the presence of thoughts of death or suicide. Mood disorders can be classified into two groups – unipolar and bipolar affective disorders. Unipolar disorders involve an abnormally persistent and severe depressed mood and are commonly known as depression. A person with this type of disorder experiences a low mood over a prolonged period of time and has difficulty managing activities like work, school, or relationships. Bipolar affective disorders, on the other hand, are characterised by extreme mood swings between elation and severe depression. Several factors can influence the development of mood disorders such as physical and psychological stress, genetic predisposition, traumatic experiences, and the presence of certain medical conditions. Also, brain chemistry abnormalities may play a role in the development of mood disorders. Structural changes in certain areas of the brain, for instance, have been linked with a higher likelihood of developing these conditions. Treatments may involve some combination of psychotherapy, medications, and lifestyle modifications depending on the severity of the disorder. Psychotherapy is aimed at helping a person identify and change negative thoughts and maladaptive behaviours that can worsen the illness, while medications can help to manage the symptoms that accompany the disorder.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom